ECSP972186A - THERAPEUTIC COMPOSITION FROM SUGAR CANE AND ITS THERAPEUTIC USES - Google Patents

THERAPEUTIC COMPOSITION FROM SUGAR CANE AND ITS THERAPEUTIC USES

Info

Publication number
ECSP972186A
ECSP972186A ECSP972186A ECSP972186A EC SP972186 A ECSP972186 A EC SP972186A EC SP972186 A ECSP972186 A EC SP972186A EC SP972186 A ECSP972186 A EC SP972186A
Authority
EC
Ecuador
Prior art keywords
therapeutic
sugar cane
methods
compositions
pathological conditions
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Gonzalo A Bermudez
Arturo E Bermudez
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP972186 priority Critical patent/ECSP972186A/en
Publication of ECSP972186A publication Critical patent/ECSP972186A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención proporciona composiciones terapeúticas derivadas de la caña de azúcar, que son útiles para el tratamiento de una variedad de afecciones patológicas en animales, particularmente el ser humano, incluyendo las causadas por inflamación, infección bacteriana, virósica o micótica; toxinas; traumatismos tales como quemaduras, y otras causas. También se proporciona métodos para preparar las composiciones terapéuticas, las fórmulas farmacéuticas que comprenden las composiciones, los métodos para el tratamiento de afecciones patológicas y los métodos para purificar los componentes activos a partir de las composiciones.The present invention provides therapeutic compositions derived from sugar cane, which are useful for the treatment of a variety of pathological conditions in animals, particularly humans, including those caused by inflammation, bacterial, viral or fungal infection; toxins; trauma such as burns, and other causes. Also provided are methods of preparing the therapeutic compositions, pharmaceutical formulas comprising the compositions, methods of treating pathological conditions, and methods of purifying the active components from the compositions.

ECSP972186 1997-07-15 1997-07-15 THERAPEUTIC COMPOSITION FROM SUGAR CANE AND ITS THERAPEUTIC USES ECSP972186A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP972186 ECSP972186A (en) 1997-07-15 1997-07-15 THERAPEUTIC COMPOSITION FROM SUGAR CANE AND ITS THERAPEUTIC USES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP972186 ECSP972186A (en) 1997-07-15 1997-07-15 THERAPEUTIC COMPOSITION FROM SUGAR CANE AND ITS THERAPEUTIC USES

Publications (1)

Publication Number Publication Date
ECSP972186A true ECSP972186A (en) 1998-11-30

Family

ID=42043017

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP972186 ECSP972186A (en) 1997-07-15 1997-07-15 THERAPEUTIC COMPOSITION FROM SUGAR CANE AND ITS THERAPEUTIC USES

Country Status (1)

Country Link
EC (1) ECSP972186A (en)

Similar Documents

Publication Publication Date Title
CY1121447T1 (en) COMPOSITIONS FOR INCREASING TELEVISION ACTIVITY
CU23208A3 (en) OXAZOLIDINONAS REPLACED AND ITS USE IN THE FIELD OF THE SANGUINEA COAGULATION
ATE361084T1 (en) TOPICAL PHARMACEUTICAL COMPOSITIONS CONTAINING PROANTHOCYANIDINS, GLYCYRRHETINIC ACID AND TELMESTEINS FOR THE TREATMENT OF DERMATITIS
DE60225556D1 (en) DPP-IV INHIBITING PURINE DERIVATIVE FOR THE TREATMENT OF DIABETES
AR013001A1 (en) DERIVATIVES OF PIPERAZINE, PROCEDURES TO PREPARE THEM, THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, THEIR USE AS A MEDICINAL PRODUCT AND THE METHOD FOR TREATING DISEASES MEDIATED BY TACHININ.
DE59712501D1 (en) 1-BENZYL-3 (SUBSTITUTED-HETARYL) -concentrated PYRAZOLE DERIVATIVES FOR THE TREATMENT OF DISEASES OF THE HEART CIRCULAR SYSTEM AND THE CENTRAL NERVOUS SYSTEM
BR0107241A (en) Compounds, process of preparation of compounds, use of compounds, fungicidal compositions, process of preventive or curative control of plant pathogenic fungi of the cultures and method of preventive or curative treatment of construction wood
ATE355374T1 (en) THERAPEUTIC AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF AMYLOIDOGENIC DISEASES
BRPI0418251B8 (en) phosphonates, monophosphonamidates, bisphosphonamidates, and pharmaceutical composition comprising them
ES2170141T3 (en) 4-AMINODERIVATES OF MYCOPHENOLIC ACID WITH IMMUNOSUPPRESSING ACTIVITY.
BR0312232A (en) Caspase inhibitors and their uses
BR9708114A (en) Xanthone analogues for the treatment of infectious diseases.
BRPI0418157A (en) allogeneic tumor therapy
DK284386D0 (en) PHARMACEUTICAL PREPARATION FOR SKIN DISORDERS
DE69819110D1 (en) A medicine to treat obesity and improve lipid metabolism
BR9712141A (en) Application of 1-hyphroxy-2-pyridones to treat skin infections.
DE60031016D1 (en) Use of antiseptics for the preparation of medicaments for the prophylaxis and treatment of inflammation in the interior of the human body
TR200100637T2 (en) New natural product derivatives
CA2340734A1 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases
DE60027127D1 (en) Use of polyamino acid derivatives for the treatment of seborrhoea and related skin disorders
ES2110057T3 (en) MEDICINAL COMPOSITION CONTAINING TCF-II.
RU95110774A (en) Oligonulceotides, therapeutical compositions, and use of compositions
ECSP972186A (en) THERAPEUTIC COMPOSITION FROM SUGAR CANE AND ITS THERAPEUTIC USES
GT199900083A (en) THERAPEUTIC COMBINATIONS FOR MUSCULOSKELETAL FRAGILITY.
DK0561882T3 (en) Hydroxamic acid derivatives which inhibit lipoxygenase